Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-Lipoic Acid in Sepsis
NCT05808946Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of alpha-lipoic acid in sepsis (2 arms), sponsored by Ain Shams University. Primary endpoint: Mortality at 28 days. Status: unknown.
02
Drugs
alpha-lipoic acid
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT05808946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05808946.